000 | 01949 a2200565 4500 | ||
---|---|---|---|
005 | 20250517133254.0 | ||
264 | 0 | _c20171122 | |
008 | 201711s 0 0 eng d | ||
022 | _a2326-6074 | ||
024 | 7 |
_a10.1158/2326-6066.CIR-16-0061-T _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHekim, Can | |
245 | 0 | 0 |
_aDasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. _h[electronic resource] |
260 |
_bCancer immunology research _c02 2017 |
||
300 |
_a157-169 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDasatinib _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunomodulation _xdrug effects |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _xdrug effects |
650 | 0 | 4 | _aMelanoma, Experimental |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
650 | 0 | 4 |
_aTumor Burden _xdrug effects |
700 | 1 | _aIlander, Mette | |
700 | 1 | _aYan, Jun | |
700 | 1 | _aMichaud, Erin | |
700 | 1 | _aSmykla, Richard | |
700 | 1 | _aVähä-Koskela, Markus | |
700 | 1 | _aSavola, Paula | |
700 | 1 | _aTähtinen, Siri | |
700 | 1 | _aSaikko, Leena | |
700 | 1 | _aHemminki, Akseli | |
700 | 1 | _aKovanen, Panu E | |
700 | 1 | _aPorkka, Kimmo | |
700 | 1 | _aLee, Francis Y F | |
700 | 1 | _aMustjoki, Satu | |
773 | 0 |
_tCancer immunology research _gvol. 5 _gno. 2 _gp. 157-169 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/2326-6066.CIR-16-0061-T _zAvailable from publisher's website |
999 |
_c26771472 _d26771472 |